School of Chemistry, University of Bristol, Bristol, UK.
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.
Gut. 2022 May;71(5):871-878. doi: 10.1136/gutjnl-2021-324588. Epub 2021 Jun 29.
To determine if oesophago-gastro-duodenoscopy (OGD) generates increased levels of aerosol in conscious patients and identify the source events.
A prospective, environmental aerosol monitoring study, undertaken in an ultraclean environment, on patients undergoing OGD. Sampling was performed 20 cm away from the patient's mouth using an optical particle sizer. Aerosol levels during OGD were compared with tidal breathing and voluntary coughs within subject.
Patients undergoing bariatric surgical assessment were recruited (mean body mass index 44 and mean age 40 years, n=15). A low background particle concentration in theatres (3 L) enabled detection of aerosol generation by tidal breathing (mean particle concentration 118 L). Aerosol recording during OGD showed an average particle number concentration of 595 L with a wide range (3-4320 L). Bioaerosol-generating events, namely, coughing or burping, were common. Coughing was evoked in 60% of the endoscopies, with a greater peak concentration and a greater total number of sampled particles than the patient's reference voluntary coughs (11 710 vs 2320 L and 780 vs 191 particles, n=9 and p=0.008). Endoscopies with coughs generated a higher level of aerosol than tidal breathing, whereas those without coughs were not different to the background. Burps also generated increased aerosol concentration, similar to those recorded during voluntary coughs. The insertion and removal of the endoscope were not aerosol generating unless a cough was triggered.
Coughing evoked during OGD is the main source of the increased aerosol levels, and therefore, OGD should be regarded as a procedure with high risk of producing respiratory aerosols. OGD should be conducted with airborne personal protective equipment and appropriate precautions in those patients who are at risk of having COVID-19 or other respiratory pathogens.
确定清醒患者行上消化道内镜检查(OGD)时是否会产生更高水平的气溶胶,并确定其来源事件。
在超净环境中对接受 OGD 的患者进行前瞻性环境气溶胶监测研究。使用光学粒子计数器在距患者口腔 20cm 处进行采样。在患者体内,通过比较 OGD 期间与呼吸和自愿咳嗽时的气溶胶水平。
招募了接受减肥手术评估的患者(平均体重指数为 44,平均年龄为 40 岁,n=15)。手术室中的背景粒子浓度较低(3L),可检测到呼吸时的气溶胶产生(平均粒子浓度为 118L)。OGD 期间的气溶胶记录显示平均粒子数浓度为 595L,范围很宽(3-4320L)。常见的生物气溶胶产生事件,即咳嗽或打嗝。在 60%的内镜检查中诱发了咳嗽,其峰值浓度和采样粒子总数均高于患者的参考自愿咳嗽(11710L 对 2320L 和 780 对 191 个粒子,n=9,p=0.008)。有咳嗽的内镜检查产生的气溶胶水平高于呼吸,而没有咳嗽的则与背景相同。打嗝也会产生更高的气溶胶浓度,与自愿咳嗽时记录的相似。除非引发咳嗽,否则插入和取出内镜不会产生气溶胶。
OGD 期间诱发的咳嗽是增加气溶胶水平的主要来源,因此,OGD 应被视为一种产生呼吸道气溶胶风险较高的程序。对于有 COVID-19 或其他呼吸道病原体风险的患者,应在进行 OGD 时佩戴空气传播个人防护设备和采取适当的预防措施。